Early Detection of Pancreatic Cancer

Finally there is hope for early detection of pancreatic cancer. At the age of 15, Jack Andraka discovered a protein that can be found in high levels in the blood stream early on during the disease process.

Due to current testing for pancreatic cancer being expensive and inaccurate, 85% are diagnosed too late for treatment to be effective. The 5 year survival rate is 6%. The protein that Jack found to be common in early stage pancreatic cancers is called mesothelin. This is the same protein that is found in abundance in lung and ovarian cancer patients. Jack’s breakthrough using a simple paper sensor can be used to detect other proteins that are biomarkers for additional cancers and other diseases.

Since his discovery, Jack has patented his potentially life-saving innovation. Hopefully, our bureaucratic healthcare system will not waste more time and money getting this diagnostic test distributed to those who need it.

Click here to watch Jack during his inspiring TED Talks presentation!

 

 

 

This entry was posted in blog, Jack Andraka, mesothelin, pancreatic cancer. Bookmark the permalink.

Comments are closed.

Switch to our mobile site